CHRS vs VRTX: Which Stock is Better?
Side-by-side comparison of Coherus Oncology Inc and Vertex Pharmaceuticals Inc in 2026
CHRS
Coherus Oncology Inc
$1.99
VRTX
Vertex Pharmaceuticals Inc
$439.18
Key Metrics Comparison
| Metric | CHRS | VRTX | Winner |
|---|---|---|---|
| Market Cap | $296.78M | $112.22B | VRTX |
| P/E Ratio | N/A | 28.82 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | 0.6% | 0.1% | CHRS |
| Gross Margin | 67.2% | 53.7% | CHRS |
Analyze CHRS
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHRS or VRTX a better investment?
Comparing CHRS and VRTX: Coherus Oncology Inc has a market cap of $296.78M while Vertex Pharmaceuticals Inc has $112.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHRS and VRTX?
CHRS (Coherus Oncology Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHRS or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHRS or VRTX?
CHRS has higher revenue growth at 0.6% vs 0.1% for VRTX.
Which company is more profitable: CHRS or VRTX?
Coherus Oncology Inc (CHRS) has higher gross margins at 67.2% compared to 53.7% for VRTX.
Which is the larger company: CHRS or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $112.22B compared to $296.78M for CHRS.
Should I buy CHRS or VRTX in 2026?
Both CHRS and VRTX have investment merit. CHRS trades at $1.99 while VRTX trades at $439.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHRS and VRTX stock?
Key differences: Market Cap ($296.78M vs $112.22B), P/E Ratio (N/A vs 28.8x), Revenue Growth (0.6% vs 0.1%), Gross Margin (67.2% vs 53.7%).